One inflammation-related mechanistic link between microbiota and cancer is the NF-κB pathway, as demonstrated by a study of mice deficient of TLR-4 (a receptor of LPS and an upstream regulator of NF-κB), whereby tumour development was reduced compared to wild type mice [149]. This evidence concerns the gene NFKB1 and cancer.